Skip to main content
Figure 5 | Cancer Cell International

Figure 5

From: An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study

Figure 5

Measurement of ROS production in control and ESE-16-treated blood samples. Hydrogen peroxide detection utilizing DCFDA probe of control blood samples (A) and ESE-16-treated samples (B) showed no statistical difference. Superoxide detection utilizing HE probe indicated control blood samples (C) and ESE-16-treated blood samples (D) which once again indicated not statistically significant (a P-value of less than 0.05 was accepted as statistically significant).

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us